ReviewCardiovascular diabetology2021

Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug.

Lorenzo Nesti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.